Rubén Fernández-Álvarez

Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

Christopher P. Fox, Monica Civallero, Young-Hyeh Ko et al. · The Lancet Haematology · 2020 · 133 citations · Full text

Lymphoid Neoplasia, Survival Outcomes, Medicine +7

Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients.

Cartón Ja, Maradona Ja, Nuño Mateo Fj et al. · PubMed · 1992 · 111 citations

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Carlos Jiménez‐Cortegana, Natalia Palazón‐Carrión, Alejandro Martı́n et al. · Journal for ImmunoTherapy of Cancer · 2021 · 60 citations · Full text

Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients

Rubén Fernández-Álvarez, Ana Pilar González, Arturo Rubio-Castro et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 33 citations · Full text

Immunodeficiencies, Immunology, Plasmablastic Lymphoma +16

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

Juan‐Manuel Sancho, Rubén Fernández-Álvarez, Francisco Gual‐Capllonch et al. · Cancer Medicine · 2021 · 28 citations · Full text